Plastic Surgery Doctors in Ponte Vedra Beach, FL Accepting Medicare

4 Plastic Surgery doctors found. Showing 1 - 4

Mr. James E Hardy Iii, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 232 Ponte Vedra Park Dr, Ponte Vedra Beach, FL 32082 Phone: 904-285-7546    Fax: 904-273-8511

Daniel M Calloway, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 6000b 1 Sawgrass Village Circle, Ponte Vedra Beach, FL 32082 Phone: 904-273-8280    Fax: 904-273-4724

Robert Gregory Smith, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 150 Professional Drive, Suite 100, Ponte Vedra Beach, FL 32082 Phone: 904-285-5571    Fax: 904-285-6957

Roberto Eloy Garcia, MD Plastic Surgery - Plastic Surgery Within the Head and Neck Medicare: Not Enrolled in Medicare Practice Location: 230 A1a N, Ponte Vedra Beach, FL 32082 Phone: 904-686-8020    Fax: 904-834-2592

News Archive

Genetic test identifies breast cancer patients that can avoid chemotherapy and remain relapse-free following five years of hormone therapy

Genomic Health has announced the presentation of the first results1 from the Trial Assigning IndividuaLised Options for Treatment (Rx), or TAILORx, a large, prospectively conducted trial designed and conducted by the ECOG-ACRIN Cancer Research Group under the sponsorship of the U.S. National Cancer Institute (NCI).

Even mild head injuries can cause abnormalities in brain function

Even mild head injuries can cause significant abnormalities in brain function that last for several days, which may explain the neurological symptoms experienced by some individuals who have experienced a head injury associated with sports, accidents or combat, according to a study by Virginia Commonwealth University School of Medicine researchers.

Ocugen's OCU100 gets FDA orphan drug designation for treatment of retinitis pigmentosa

Ocugen, Inc. and the University of Colorado today announced exclusive license agreements that allow for Ocugen to continue developing two drug candidates for the treatment for ophthalmology indications, and that one of the assets, OCU100, recombinant lens epithelium derived growth factor 1-326 (LEDGF1-326), received orphan-drug status from the U.S. Food and Drug Administration for treatment of retinitis pigmentosa (RP), a rare eye disease.

Novel robot can aid treatment of rare birth defect

Researchers at the University of Sheffield and Boston's Children Hospital, Harvard Medical School have created a robot that can be implanted into the body to aid the treatment of esophageal atresia, a rare birth defect that affects a baby's esophagus.

Researchers identify two cell-signaling molecules that appear critical to stalling cancer's spread

In what is believed to be the largest epigenetic analysis to date of cell-signaling molecules in early-stage melanoma, researchers at NYU Langone Medical Center and its Laura and Isaac Perlmutter Cancer Center have identified two tiny bits of non-coding genetic material in primary tumors that appear critical to stalling the cancer's spread - and essentially setting the biological fate of the disease.

Read more Medical News

› Verified 8 days ago